2022
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
Astrazeneca
|
|
Pfizer
|
|
Johnson and Johnson
|
|
Moderna
|
Detailed explanation-1: -Spikevax is a monovalent COVID-19 vaccine that is approved for use as a two-dose primary series for the prevention of COVID-19 in individuals 18 years of age and older. It is also authorized for emergency use to provide: A two-dose primary series to individuals 12 years through 17 years of age.
Detailed explanation-2: -“At two syllables with a vax suffix, that’s considered a big win from a branding standpoint in the pharma and vaccine industry,” Scott Piergrossi, Brand Institute president of operations and communications, said. Brand Institute developed the Spikevax moniker, as well as the Comirnaty and Vaxzevria brand names.
Detailed explanation-3: -The Pfizer, Moderna, Johnson & Johnson (J&J), and Novavax COVID-19 vaccines are available for use in the U.S. The Pfizer vaccine and Moderna vaccine are FDA-approved. The FDA has limited the use of the J&J vaccine to certain people. The CDC recommends a single bivalent (updated) booster shot in people ages 5 and older.